The therapeutic potential of IGF-I in skeletal muscle repair

被引:79
|
作者
Song, Yao-Hua [1 ]
Song, Jenny L. [1 ]
Delafontaine, Patrice [2 ]
Godard, Michael P. [3 ]
机构
[1] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Cyrus Tang Hematol Ctr, Suzhou 215123, Peoples R China
[2] Tulane Univ, Sch Med, Inst Heart & Vasc, New Orleans, LA 70112 USA
[3] Cent Missouri State Univ, Dept Nutr & Kinesiol, Warrensburg, MO 64093 USA
来源
关键词
muscle wasting; IGF-I; satellite cell; GROWTH-FACTOR-I; AMYOTROPHIC-LATERAL-SCLEROSIS; SPINAL MUSCULAR-ATROPHY; 2-YEAR ALS TRIAL; MOUSE MODEL; CANCER CACHEXIA; HEART-FAILURE; STEM-CELLS; FUNCTIONAL RECOVERY; SUBCUTANEOUS IGF-1;
D O I
10.1016/j.tem.2013.03.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Skeletal muscle loss due to aging, motor-neuron degeneration, cancer, heart failure, and ischemia is a serious condition for which currently there is no effective treatment. Insulin-like growth factor 1 (IGF-I) plays an important role in muscle maintenance and repair. Preclinical studies have shown that IGF-I is involved in increasing muscle mass and strength, reducing degeneration, inhibiting the prolonged and excessive inflammatory process due to toxin injury, and increasing the proliferation potential of satellite cells. However, clinical trials have not been successful due to ineffective delivery methods. Choosing the appropriate isoforms or peptides and developing targeted delivery techniques can resolve this issue. Here we discuss the latest development in the field with special emphasis on novel therapeutic approaches.
引用
收藏
页码:310 / 319
页数:10
相关论文
共 50 条
  • [21] A functional IGF-I receptor is not necessary for in vivo skeletal muscle hypertrophy
    Spangenburg, Espen E.
    LeRoith, Derek
    Bodine, Sue
    FASEB JOURNAL, 2007, 21 (06): : A1303 - A1304
  • [22] IGF-I isoforms and ageing skeletal muscle: an 'unresponsive' hypertrophy agent?
    Spangenburg, EE
    JOURNAL OF PHYSIOLOGY-LONDON, 2003, 547 (01): : 2 - 2
  • [23] Comparative evaluation of IGF-I gene transfer and IGF-I protein administration for enhancing skeletal muscle regeneration after injury
    Schertzer, J. D.
    Lynch, G. S.
    GENE THERAPY, 2006, 13 (23) : 1657 - 1664
  • [24] Alteration of spinal cord IGF-I receptors and skeletal muscle IGF-I after hind-limb immobilization in the rat
    Suliman, IA
    Lindgren, JU
    Gillberg, PG
    Elhassan, AM
    Monneron, C
    Adem, A
    NEUROREPORT, 1999, 10 (06) : 1195 - 1199
  • [25] Comparative evaluation of IGF-I gene transfer and IGF-I protein administration for enhancing skeletal muscle regeneration after injury
    J D Schertzer
    G S Lynch
    Gene Therapy, 2006, 13 : 1657 - 1664
  • [26] The ABCs of IGF-I isoforms: impact on muscle hypertrophy and implications for repair
    Barton, Elisabeth R.
    APPLIED PHYSIOLOGY NUTRITION AND METABOLISM-PHYSIOLOGIE APPLIQUEE NUTRITION ET METABOLISME, 2006, 31 (06): : 791 - 797
  • [27] Aging impairs IGF-I receptor activation and induces skeletal resistance to IGF-I
    Cao, Jay J.
    Kurimoto, Pamela
    Boudignon, Benjamin
    Rosen, Clifford
    Lima, Florence
    Halloran, Bernard P.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 (08) : 1271 - 1279
  • [28] Differential regulation of IGF-I and IGF-II gene expression in skeletal muscle cells
    Shuang Jiao
    Hongxia Ren
    Yun Li
    Jianfeng Zhou
    Cunming Duan
    Ling Lu
    Molecular and Cellular Biochemistry, 2013, 373 : 107 - 113
  • [29] Developmental expression and location of IGF-I and IGF-II mRNA and protein in skeletal muscle
    Gerrard, DE
    Okamura, CS
    Ranalletta, MAM
    Grant, AL
    JOURNAL OF ANIMAL SCIENCE, 1998, 76 (04) : 1004 - 1011
  • [30] Differential regulation of IGF-I and IGF-II gene expression in skeletal muscle cells
    Jiao, Shuang
    Ren, Hongxia
    Li, Yun
    Zhou, Jianfeng
    Duan, Cunming
    Lu, Ling
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2013, 373 (1-2) : 107 - 113